Taxonomy
The Fall 2020 CMTA Report
Inside: Special reports on virtual Camp Footprint and CMT Awareness Month CMTA and Pharnext Enter Biomarker Research Collaboration
Collaboration focused on identifying and characterizing key biomarkers
in Charcot-Marie-Tooth disease Type 1ACMT Awareness Month 2020: Be a Champion
This CMT Awareness Month, we’re celebrating YOU – our champions! We’re honoring you for facing the challenges of CMT with bravery, strength and heart.Type 2 Update: One Patient’s Diagnostic Odyssey with SORD
In "A Diagnosis Worthy of a Tattoo," CMT patient and champion fundraiser Vittorio Ricci describes how he was finally diagnosed after six years and several trips to the CMTA Center of Excellence headed by Dr. Michael Shy.The 2020 Summer CMTA Report
Coverage of COVID-19 and CMT, the discovery of a new CMT type that may be treatable with a current diabetes drug and Part 3 of "Surgical Correction of the CMT Foot"Breakthrough Guide to Orthopedic Surgery for CMT
Spearheaded by orthopedic surgeon Dr. Glenn Pfeffer, a remarkable group of surgeons defined consensus terminology, agreed upon standardized templates for history and physical examination and recommended a comprehensive approach to CMT foot surgeryCMTA Camp Footprint Has Gone Virtual for 2020
We have an exciting line-up of daily activities in store to connect and grow the Tribe of the Funky Feet. Anticipation and excitement is building, and the countdown has begun.CMTA 2019 Annual Report Highlight Reel
To compliment the publication of the 2019 CMTA Annual Report, the Youth of the CMTA created this highlight reel in celebration of all we accomplished together in 2019!Craig Zeltsar Joins CMTA Board of Directors
The Charcot-Marie-Tooth Association today welcomed Craig Zeltsar, principal and co-founder of NNE Marketing, LLC, to its Board of Directors. New, Potentially Treatable, Type of CMT Discovered
A team led by Dr. Stephan Züchner at the University of Miami has discovered a new type of Charcot-Marie-Tooth (CMT) disease that may be treatable with drugs already approved for other diseases.